Needham & Company LLC Boosts Axsome Therapeutics (NASDAQ:AXSM) Price Target to $153.00
Axsome Therapeutics (NASDAQ:AXSM – Get Free Report) had its price objective lifted by equities research analysts at Needham & Company LLC from $133.00 to $153.00 in a report released on Wednesday,Benzinga reports. The firm presently has a “buy” rating on the stock. Needham & Company LLC’s price target points to a potential upside of 18.47% […]
Axsome Therapeutics (NASDAQ:AXSM – Get Free Report) had its price objective lifted by equities research analysts at Needham & Company LLC from $133.00 to $153.00 in a report released on Wednesday,Benzinga reports. The firm presently has a “buy” rating on the stock. Needham & Company LLC’s price target points to a potential upside of 18.47% […]
